National Integrated Care Conference for Diabetes Medicines Optimisation

These meetings are intended for UK Healthcare Professionals and have been developed in accordance with the ABPI Code of Practice.

Event Name National Integrated Care Conference for Diabetes Medicines Optimisation
Location Virtual - Joining link will be sent 48 hours prior
Start Date 9:00am 17/06/2021
Finish Date 5:00pm 17/06/2021
Booking Closes No longer taking bookings
Places Available
Event Description

The PM National Integrated Care Conference for Diabetes Medicines Optimisation will take place on Thursday 17th June 2021.

 

This Conference will be delivered digitally via ZOOM.

 

Session details below;

 

FEATRURE INTERVIEW: Dr Natasha Patel FRCP EMBA, Diabetes Consultant Guys and St Thomas’ Hospital, London and Vice-Chair, South East London Diabetes Medicines Working Group

Introducing PARM Diabetes - The type 2 population health management tool co-created by Lilly Diabetes and NHS Devon CCG - This symposia slot is sponsored by Lilly - Dr Shahzada Khan GP Principal and Tutor in Diabetes, NHS Newham CCG, Mark Oliver Lilly Healthcare Development Manager, South West England

NHS White Paper: Development of Integrated Care Systems and the Impact upon Pharmacy Services - Steve Riley, Senior Policy Lead (Pharmaceutical Services), NHS England and Improvement

An overview of the development of ICSs and the impact upon pharmacy service delivery and wider primary care. What pharmacy service commissioning and delivery may look like in the future. How could the commissioming landscape change.

Where is the patient in all this? - Mark Duman, Chief Patient Officer, MD Healthcare, NW England Service Champion, Diabetes UK

  • Understanding the person behind the pancreas
  • Positioning information as a therapy
  • Embracing the heath coaching model

Initiation of a GLP-1 Receptor Agonist in Diabetes Medicines Optimisation - Michelle Lam, Diabetes Specialist Pharmacist, Senior Clinical Pharmacist, West Merton Primary Care Network

This session will provide insights to support the use of a GLP-1 receptor agonist (GLP-1RA) for treatment intensification and individualisation of therapy. It will discuss the benefits and risks, clinical and practical aspects of this class of agents, and the pharmacological differences among the GLP-1RAs. Two real-life case studies (in patients with or without insulin therapy) will be shared to illustrate the shared decision-making process.

Head, Shoulders, Kidneys & Toes a Foot Focus for Pharmacists - Matthew Heppel, Advanced Clinical Diabetes and Endocrinology Pharmacist, Hull University Teaching Hospitals, Donna Welch Podiatry Operations Manager and Professional Lead, Hull and East Riding Podiatry

A Holistic approach to Foot assessment and management in the Diabetic foot.

NHS Get It Right First Time Diabetes Report and NaDIA into practice - What every pharmacist needs to know to improve inpatient care - Claire Davies‚Äč, Diabetes and Endocrinology Specialist Pharmacist, Gateshead Health NHS Foundation Trust, Queen Elizabeth Hospital

This presentation will provide an overview of the recent NHS GIRFT Diabetes Report and National Diabetes Inpatient Audit data and will discuss the key messages and learnings from both reports. The session will explain the roles of each report, how they are compiled and how to use the results to guide and improve inpatient care for people living with diabetes. The session will focus on the role of pharmacists in inpatient diabetes care and how to utilise the data available to optimise care for people living with diabetes when in hospital.

Best Practice in the Delivery of Diabetes Care in the Primary Care Network : A Focus on Pharmacists - Hannah Beba, Senior Pharmacist for Diabetes and Endocrinology, County Durham and Darlington NHS Foundation Trust

The recent release of the recent document ‘ Best Practice in the Delivery of Diabetes Care in the Primary Care Network’ shows pharmacists to be an important part of the multiple levels of care in the delivery of excellence in care to people living with diabetes. The session will overview the document and what this means for pharmacists working in PCNs and integrated systems of care.

Integrating Diabetes Care - Bridging the gap between primary and secondary care - Hannah Syed, Diabetes Lead Pharmacist and Practice Pharmacist, East Sussex Healthcare Trust 

Integrated care has much to offer people with diabetes. However, it’s delivery can be a challenging with various barriers to overcome. This presentation shares a local approach embedding integrated diabetes care in East Sussex. This presentation describes how investment in a pharmacy leadership can improve patient outcomes, reduce variation in care and build relationships through working collaboratively across the healthcare interface.

This event is sponsored by the following companies who have had no input into the design or content of the webinar except from their own sessions.

Eli Lilly &Co - Headline Sponsor

Abbott Diabetes Care UK - Silver Sponsor

Takeda UK - Silver Sponsor

Agenda Download Agenda PDF
Contact Name Katie Fraser
More Details Email for more details.
Your booking is always provisional until we confirm it!
Join Waiting List
Website by MAXX Design

© 2021 Pharman | All rights reserved | Site Map | Accessibility | Privacy and Cookie Policy | Terms & Conditions

Confirmation

This site is intended for healthcare professionals or people employed in the pharmaceutical industry. Please confirm that you are such a person.

Continue